Reducing the global burden of HTLV-1 infection: an agenda for research and action
Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action
L Willems, H Hasegawa, R Accolla… - ANTIVIRAL …, 2017 - irinsubria.uninsubria.it
Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action
L Willems, H Hasegawa, R Accolla, C Bangham… - 2017 - arca.fiocruz.br
Even though an estimated 10e20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
L Willems, H Hasegawa, R Accolla, C Bangham… - Antiviral …, 2016 - europepmc.org
Even though an estimated 10-20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action
L Willems, H Hasegawa, R Accolla, C Bangham… - alicia.concytec.gob.pe
Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action
L Willems, H Hasegawa, R Accolla, C Bangham… - Antiviral Research, 2017 - infona.pl
Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: an agenda for research and action.
L Willems, H Hasegawa, R Accolla, C Bangham… - 2017 - cabidigitallibrary.org
Even though an estimated 10-20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action
L Willems, H Hasegawa, R Accolla, C Bangham… - Antiviral …, 2017 - hal.science
Even though an estimated 10-20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action
L Willems, H Hasegawa, R Accolla… - ANTIVIRAL …, 2017 - research.unipd.it
Even though an estimated 10-20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
Reducing the global burden of HTLV-1 infection: An agenda for research and action
L Willems, H Hasegawa, R Accolla… - ANTIVIRAL …, 2017 - art.torvergata.it
Even though an estimated 10-20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …